Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in BNR held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Kynam Capital Management, LP | 1.2M | $19.8M | +23.4% | 115.476% | 1.24% |
| 2 | CRCM LP | 282K | $4.6M | -42.6% | 26.537% | 3.26% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 35K | $571K | +13.8% | 3.331% | 0.00% |
| 4 | Nikko Asset Management Americas, Inc. | 30K | $488K | -5.3% | 2.835% | 0.01% |
| 5 | Sumitomo Mitsui Trust Holdings, Inc. | 30K | $486K | -5.3% | 2.835% | 0.00% |
| 6 | BANK OF AMERICA CORP /DE/ | 29K | $470K | -0.1% | 2.743% | 0.00% |
| 7 | Redwood Wealth Management Group, LLC | 18K | $295K | -8.7% | 1.719% | 0.13% |
| 8 | CITADEL ADVISORS LLC | 18K | $285K | — | 1.662% | 0.00% |
| 9 | MORGAN STANLEY | 15K | $246K | +29.0% | 1.437% | 0.00% |
| 10 | SC CHINA HOLDING Ltd | 21K | $62K | 0.0% | 1.995% | 0.00% |
| 11 | BNP PARIBAS ARBITRAGE, SA | 3K | $45K | 0.0% | 0.263% | 0.00% |
| 12 | UBS Group AG | 408 | $7K | -65.1% | 0.038% | 0.00% |
| 13 | Tower Research Capital LLC (TRC) | 28 | $452 | — | 0.003% | 0.00% |
| 14 | BlackRock, Inc. | 4 | $65 | -60.0% | 0.000% | 0.00% |
| 15 | CITIGROUP INC | 1 | $16 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in BNR — a direct measure of their conviction.
Filings activity in BNR during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new BNR position in Q1 2026
Institutions that fully closed their BNR position in Q1 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 15 | 12% | 199.99% | +0.00 pp | $27M | 22% |
| Q4 2025 | 17 | +13% | 199.99% | +64.88 pp | $35M | +183% |
| Q3 2025 | 15 | 21% | 135.11% | 64.88 pp | $12M | 94% |
| Q2 2025 | 19 | +5.6% | 199.99% | +94.82 pp | $201M | +1992% |
| Q1 2025 | 18 | 18% | 105.17% | 67.53 pp | $10M | 39% |
| Q4 2024 | 22 | +16% | 172.70% | +99.84 pp | $16M | +137% |
| Q3 2024 | 19 | +0.0% | 72.86% | 70.68 pp | $7M | 49% |
| Q2 2024 | 19 | — | 143.54% | — | $13M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying BNR stock.
Based on Q1 2026 13F filings, institutional ownership of Burning Rock Biotech Limited stands at 200.0%, held across 15 reporting institutions.
Kynam Capital Management, LP is the largest reported institutional holder of BNR, with approximately 1,227,555 shares worth $0.02B as of Q1 2026.
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of BNR, including RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC.
Our composite Smart Money Score for BNR is 46 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
2 institutions opened new positions in BNR during Q1 2026, while 4 fully exited. 1 added to existing positions and 12 trimmed.
BNR institutional ownership rose by 0.00 percentage points quarter-over-quarter, with a net change of -2 holders.
The top 10 institutions account for 99.8% of all reported 13F value in BNR, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Burning Rock Biotech Limited (BNR) Institutional Ownership